MedTrace Logo

Tranexamic Acid and Blood Clots in Knee Surgery

NCT02867163 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2019-05-20

Study results available
· View outcomes & findings →

Summary

This is an observational trial to estimate the incidence of deep vein thrombosis (DVT) in total knee replacement patients who received an intraoperative dose of tranexamic acid.

Conditions

  • Venous Thrombosis

Interventions

DRUG

Tranexamic Acid

Intravenous or local administration of TXA, in any dosage

Sponsors & Collaborators

  • University of New Mexico

    lead OTHER

Principal Investigators

  • David Siegel, MD · University of New Mexico

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-16
Primary Completion
2017-11-08
Completion
2017-11-08

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02867163 on ClinicalTrials.gov